Skip to main content
Erschienen in: Neuroradiology 5/2014

01.05.2014 | Diagnostic Neuroradiology

Diagnostic accuracy of short-time inversion recovery sequence in Graves’ ophthalmopathy before and after prednisone treatment

verfasst von: Fabio Tortora, Mariaevelina Prudente, Mario Cirillo, Andrea Elefante, Maria Paola Belfiore, Francesco Romano, Salvatore Cappabianca, Carlo Carella, Sossio Cirillo

Erschienen in: Neuroradiology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In Graves’ Ophthalmopathy, it is important to distinguish active inflammatory phase, responsive to immunosuppressive treatment, from fibrotic unresponsive inactive one. The purpose of this study is, first, to identify the relevant orbital magnetic resonance imaging signal intensities before treatment, so to classify patients according to their clinical activity score (CAS), discriminating inactive (CAS < 3) from active Graves’ Ophthalmopathy (GO) (CAS > 3) subjects and, second, to follow post-steroid treatment disease.

Methods

An observational study was executed on 32 GO consecutive patients in different phases of disease, based on clinical and orbital Magnetic Resonance Imaging parameters, compared to 32 healthy volunteers. Orbital Magnetic Resonance Imaging was performed on a 1.5 tesla Magnetic Resonance Unit by an experienced neuroradiologist blinded to the clinical examinations.

Results

In pre-therapy patients, compared to controls, a medial rectus muscle statistically significant signal intensity ratio (SIR) in short-time inversion recovery (STIR) (long TR/TE) sequence was found, as well as when comparing patients before and after treatment, both medial and inferior rectus muscle SIR resulted significantly statistically different in STIR. These increased outcomes explain the inflammation oedematous phase of disease, moreover after steroid administration, compared to controls; patients presented lack of that statistically significant difference, thus suggesting treatment effectiveness.

Conclusion

In our study, we proved STIR signal intensities increase in inflammation oedematous phase, confirming STIR sequence to define active phase of disease with more sensibility and reproducibility than CAS alone and to evaluate post-therapy involvement.
Literatur
1.
Zurück zum Zitat Dickinson AJ, Perros P (2009) Thyroid-associated orbitopathy: who and how to treat. Endocrinol Metab Clin N Am 38:373–388CrossRef Dickinson AJ, Perros P (2009) Thyroid-associated orbitopathy: who and how to treat. Endocrinol Metab Clin N Am 38:373–388CrossRef
2.
Zurück zum Zitat Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of detailed protocol with comparative photographs for objective assessment. Clin Endocrinol 55(3):224–225 Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of detailed protocol with comparative photographs for objective assessment. Clin Endocrinol 55(3):224–225
3.
Zurück zum Zitat Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M et al (2009) Treatment modalities for Graves’ Ophthalmopathy: systematic review and meta-analysis. Clin Endocrinol Metab 94(8):2708–2716CrossRef Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M et al (2009) Treatment modalities for Graves’ Ophthalmopathy: systematic review and meta-analysis. Clin Endocrinol Metab 94(8):2708–2716CrossRef
4.
Zurück zum Zitat Kirsch EC, Kaim AH, De Oliveira MG et al (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible redictor of therapy response in Graves’ orbitopathy—a pilot study at 1.5 T. Neuroradiology 52:91–97PubMedCrossRef Kirsch EC, Kaim AH, De Oliveira MG et al (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible redictor of therapy response in Graves’ orbitopathy—a pilot study at 1.5 T. Neuroradiology 52:91–97PubMedCrossRef
5.
Zurück zum Zitat Prummel MF, Gerding MN, Zonneveld FW et al (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves’ Ophthalmopathy. Clin Endocrinol 54(2):205–209CrossRef Prummel MF, Gerding MN, Zonneveld FW et al (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves’ Ophthalmopathy. Clin Endocrinol 54(2):205–209CrossRef
6.
Zurück zum Zitat Cakirer S, Cakirer D, Basak M et al (2004) Evaluation of extraocular muscles in the edematous phase of Graves Ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28(1):80–86PubMedCrossRef Cakirer S, Cakirer D, Basak M et al (2004) Evaluation of extraocular muscles in the edematous phase of Graves Ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28(1):80–86PubMedCrossRef
7.
Zurück zum Zitat Mourits MP, Prummel MF, Wiersinga WM et al (1997) Clinical activity score as a guide in the management of patients with Graves’ Ophthalmopathy. Clin Endocrinol 47:9–14CrossRef Mourits MP, Prummel MF, Wiersinga WM et al (1997) Clinical activity score as a guide in the management of patients with Graves’ Ophthalmopathy. Clin Endocrinol 47:9–14CrossRef
8.
Zurück zum Zitat Bartalena L, Baldeschi L, Dickinson AJ et al (2008) Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18:333–346PubMedCrossRef Bartalena L, Baldeschi L, Dickinson AJ et al (2008) Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18:333–346PubMedCrossRef
9.
Zurück zum Zitat Bartalena L, Eckstein A, Kendall-Taylor P et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285PubMedCrossRef Bartalena L, Eckstein A, Kendall-Taylor P et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285PubMedCrossRef
10.
Zurück zum Zitat Amano Y, Amano M, Kumazaki T (1997) Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings. AJNR Am J Neuroradiol 18:161–164PubMed Amano Y, Amano M, Kumazaki T (1997) Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings. AJNR Am J Neuroradiol 18:161–164PubMed
11.
Zurück zum Zitat Taoka T, Iwasaki S, Uchida H et al (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. Acta Radiol 41:211–216PubMedCrossRef Taoka T, Iwasaki S, Uchida H et al (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. Acta Radiol 41:211–216PubMedCrossRef
12.
Zurück zum Zitat Kirsch E, Hammer B, von Arx G (2009) Graves’ orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed Kirsch E, Hammer B, von Arx G (2009) Graves’ orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed
13.
Zurück zum Zitat Mourits MP (2007) Diagnosis and differential diagnosis of Graves’ Orbitopathy. In: Wiersinga WM, Kahaly GJ (eds) Graves’ Orbitopathy: A multidisciplinary approach. Karger, Basel, pp 66–77CrossRef Mourits MP (2007) Diagnosis and differential diagnosis of Graves’ Orbitopathy. In: Wiersinga WM, Kahaly GJ (eds) Graves’ Orbitopathy: A multidisciplinary approach. Karger, Basel, pp 66–77CrossRef
14.
Zurück zum Zitat Ceccarelli C, Bencivelli W, Vitti P et al (2005) Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years retrospective study. Clin Endocrinol 62:331–335CrossRef Ceccarelli C, Bencivelli W, Vitti P et al (2005) Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years retrospective study. Clin Endocrinol 62:331–335CrossRef
15.
Zurück zum Zitat Tachibana S, Murakami T, Noguchi H et al (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ Ophthalmopathy. Endocr J 57(10):853–861PubMedCrossRef Tachibana S, Murakami T, Noguchi H et al (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves’ Ophthalmopathy. Endocr J 57(10):853–861PubMedCrossRef
16.
Zurück zum Zitat Mourits MP, Koornneef L, Wiersinga WM et al (1989) Clinical criteria for the assessment of disease activity in Graves’ Ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644PubMedCentralPubMedCrossRef Mourits MP, Koornneef L, Wiersinga WM et al (1989) Clinical criteria for the assessment of disease activity in Graves’ Ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Wiersinga WM, Perros P, Kahaly GJ et al (2006) Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387–389PubMedCrossRef Wiersinga WM, Perros P, Kahaly GJ et al (2006) Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387–389PubMedCrossRef
19.
Zurück zum Zitat Hoang JK, Eastwood JD, Glastonbury CM (2010) What’s in a name? Eponyms in head and neck imaging. Clin Radiol 65(3):237–245PubMedCrossRef Hoang JK, Eastwood JD, Glastonbury CM (2010) What’s in a name? Eponyms in head and neck imaging. Clin Radiol 65(3):237–245PubMedCrossRef
20.
Zurück zum Zitat Nagy EV, Toth J, Kaldi I et al (2000) Graves’ Ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol 142:591–597PubMedCrossRef Nagy EV, Toth J, Kaldi I et al (2000) Graves’ Ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol 142:591–597PubMedCrossRef
21.
Zurück zum Zitat Mayer E, Herdman G, Burnett C et al (2001) Se- trial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease. Eyes 15:313 Mayer E, Herdman G, Burnett C et al (2001) Se- trial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease. Eyes 15:313
22.
Zurück zum Zitat Mayer EJ, Fox DL, Herdman G et al (2005) Signal intensity, clinical activity and cross sectional areas on MRI scans in thyroid eye disease. Eur J Radiol 56:20–24PubMedCrossRef Mayer EJ, Fox DL, Herdman G et al (2005) Signal intensity, clinical activity and cross sectional areas on MRI scans in thyroid eye disease. Eur J Radiol 56:20–24PubMedCrossRef
23.
Zurück zum Zitat Lennerstrand G, Tian S, Isberg B et al (2007) MRI measurements of normal extraocular muscles in thyroid associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 5:192–201CrossRef Lennerstrand G, Tian S, Isberg B et al (2007) MRI measurements of normal extraocular muscles in thyroid associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand 5:192–201CrossRef
24.
Zurück zum Zitat Yokoyama N, Nagataki S, Uetani M et al (2002) Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid 12:223–227PubMedCrossRef Yokoyama N, Nagataki S, Uetani M et al (2002) Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid 12:223–227PubMedCrossRef
25.
Zurück zum Zitat Utech CI, Khatibnia U, Winter PF et al (1995) MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves’ Ophthalmopathy. Thyroid 5(3):185–193PubMed Utech CI, Khatibnia U, Winter PF et al (1995) MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves’ Ophthalmopathy. Thyroid 5(3):185–193PubMed
26.
Zurück zum Zitat Ott M, Breiter N, Albrecht CF et al (2002) Can contrast enhanced MRI predict the responce of Graves’ Ophthalmopathy to orbital radiotherapy? Br J Radiol 75:514–517PubMed Ott M, Breiter N, Albrecht CF et al (2002) Can contrast enhanced MRI predict the responce of Graves’ Ophthalmopathy to orbital radiotherapy? Br J Radiol 75:514–517PubMed
Metadaten
Titel
Diagnostic accuracy of short-time inversion recovery sequence in Graves’ ophthalmopathy before and after prednisone treatment
verfasst von
Fabio Tortora
Mariaevelina Prudente
Mario Cirillo
Andrea Elefante
Maria Paola Belfiore
Francesco Romano
Salvatore Cappabianca
Carlo Carella
Sossio Cirillo
Publikationsdatum
01.05.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 5/2014
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-014-1332-4

Weitere Artikel der Ausgabe 5/2014

Neuroradiology 5/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.